These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 10330384)

  • 1. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
    Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y
    Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
    Ahmad S; Haas S; Hoppensteadt DA; Lietz H; Reid U; Bender N; Messmore HL; Misselwitz F; Bacher P; Gaikwad BS; Jeske WP; Walenga JM; Fareed J
    Thromb Res; 2002 Oct; 108(1):49-55. PubMed ID: 12586132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
    Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.
    Lubenow N; Hinz P; Thomaschewski S; Lietz T; Vogler M; Ladwig A; Jünger M; Nauck M; Schellong S; Wander K; Engel G; Ekkernkamp A; Greinacher A
    Blood; 2010 Mar; 115(9):1797-803. PubMed ID: 19965682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
    J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
    Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
    Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
    Visentin GP; Malik M; Cyganiak KA; Aster RH
    J Lab Clin Med; 1996 Oct; 128(4):376-83. PubMed ID: 8833886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
    Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
    Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia.
    Gruel Y; Pouplard C; Nguyen P; Borg JY; Derlon A; Juhan-Vague I; Regnault V; Samama M;
    Br J Haematol; 2003 Jun; 121(5):786-92. PubMed ID: 12780795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery.
    Trossaërt M; Gaillard A; Commin PL; Amiral J; Vissac AM; Fressinaud E
    Br J Haematol; 1998 Jun; 101(4):653-5. PubMed ID: 9674736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
    Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
    Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
    J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
    J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin ELISA test.
    Elalamy I; Potevin F; Lecrubier C; Bara L; Marie JP; Samama MM
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):665-71. PubMed ID: 8958387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
    Amiral J
    Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.